MEDICINOVA, INC. Operating Lease Right-of-Use Assets
MEDICINOVA, INC. (MNOV) had Operating Lease Right-of-Use Assets of $101.97 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-13
- 2026-06-30: Operating Lease, Right-of-Use Asset $101.97K.
- 2026-03-31: Operating Lease, Right-of-Use Asset $143.68K.
- 2025-12-31: Operating Lease, Right-of-Use Asset $184.23K.
- 2025-09-30: Operating Lease, Right-of-Use Asset $223.70K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $101.97K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $143.68K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $184.23K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $223.70K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $265.44K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $312.22K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $356.90K 10-K · filed 2026-03-10 |
| 2024-09-30 | $403.89K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $443.17K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $519.31K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $575.41K 10-K · filed 2025-02-19 |
| 2023-09-30 | $617.87K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $669.31K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $579.59K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $629.50K 10-K · filed 2024-02-15 |
| 2022-09-30 | $673.09K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $722.82K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $779.04K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $824.22K 10-K/A · filed 2023-03-28 |
| 2021-09-30 | $881.75K 10-Q · filed 2021-11-12 |
| 2020-12-31 | $170.86K 10-K · filed 2022-02-16 |
| 2019-12-31 | $400.00K 10-K · filed 2020-02-13 |
| 2019-09-30 | $400.00K 10-Q · filed 2019-10-24 |
| 2019-06-30 | $500.00K 10-Q · filed 2019-07-25 |
| 2019-03-31 | $300.00K 10-Q · filed 2019-04-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |